A polymer-based gene replacement therapy developed by Qiu et al. for lung CF involved screening of various poly(β-amino esters) (PAE) to create non-viral delivery systems that were utilized for restoring CFTR function. The gene discussed is CFTR; the disease is cystic fibrosis.